Hikma Pharmaceuticals PLC

HKMPF · OTC
Analyze with AI
6/30/2025
12/31/2024
6/30/2024
12/31/2023
Operating Activities
Net Income$238$133$226$59
Dep. & Amort.$107$98$102$48
Deferred Tax$0$0$0$0
Stock-Based Comp.$16$12$15$15
Change in WC-$125$10-$223$139
Other Non-Cash-$102$58$44$125
Operating Cash Flow$161$366$198$386
Investing Activities
PP&E Inv.-$68-$96-$69-$85
Net Acquisitions$0-$150$0-$88
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.-$163-$22-$41-$41
Investing Cash Flow-$231-$268-$110-$214
Financing Activities
Debt Repay.$184$24$47-$124
Stock Issued$0$0$0$0
Stock Repurch.-$2-$37$0$0
Dividends Paid-$106-$71-$104-$55
Other Fin. Act.$67-$3$43-$60
Financing Cash Flow$143-$87-$14-$239
Forex Effect$2-$4-$9$0
Net Chg. in Cash$236-$48$31-$67
Supplemental Information
Beg. Cash$0$236$205$272
End Cash$236$188$236$205
Free Cash Flow$93$270$129$301